From professional translators, enterprises, web pages and freely available translation repositories.
bcrp
om,
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bcrp substrates
supstrati bcrp
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
mechanism: bcrp
mehanizam: bcrp
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
(bcrp inhibition)
(inhibicija bcrp-a)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
interactions with bcrp
interakcije s bcrp-om
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
(intestinal bcrp inhibition)
(inhibicija bcrp-a u crijevima)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bcrp, mrp2, oat3 and oct1 substrates
supstrati bcrp, mrp2, oat3 i oct1
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
medicinal products transported by bcrp
lijekovi koji se prenose putem bcrp prijenosnika
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
(inhibition of oatp1b and bcrp)
(inhibicija oatp1b i bcrp-a)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
(cyp3a4/5 or bcrp inhibition)
(inhibicija cyp3a4/5 i bcrp)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
inhibition of oatp 1b1 and bcrp by daclatasvir
daklatazvir inhibira oatp1b1 i bcrp.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
dasabuvir is an inhibitor of bcrp in vivo.
dasabuvir je inhibitor bcrp-a in vivo.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
(inhibition of drug transporters oatp and bcrp)
(inhibicija prijenosnika lijekova oatp i bcrp)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
(oatp1b1/3, bcrp transporter inhibition)
(inhibicija oatp1b1/3, bcrp prijenosnika)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bcrp, oatp1b1, oatp1b3 and p-gp substrates
bcrp, oatp1b1, oatp1b3 i p-gp supstrati
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
metabolite m-5 is a weak bcrp-substrate.
metabolit m-5 je slabi bcrp supstrat.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bedaquiline was not a substrate of mrp2 and bcrp in vitro.
bedakilin nije bio supstrat mrp2 i bcrp in vitro.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
lapatinib inhibits the transport proteins bcrp and oatp1b1 in vitro.
lapatinib inhibira prijenosne proteine bcrp i oatp1b1 in vitro.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
caution is advised when cresemba is given concomitantly with substrates of bcrp.
preporučuje se oprez kod istodobne primjene lijeka cresemba sa supstratima za bcrp.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
expected due to inhibition of oatp 1b1 and/or bcrp by daclatasvir:
budući da daklatazvir inhibira oatp 1b1 i/ili bcrp, očekuje se:
Last Update: 2017-04-26
Usage Frequency: 1
Quality: